| 4598 Delta-Fly Pharma, Inc. |
| 12/08/2025 15:30 | Update for DFP-10917 related clinical studies |
| 11/06/2025 15:30 | Progress status of DFP-10917 involved clinical studies |
| 08/18/2025 15:30 | First Patient Enrolled in Phase 2/3 Randomized Study of DFP-17729 for Pancreatic Cancer in Japan |
| 08/06/2025 15:30 | Progress status for Phase 1/2 study of DFP-10917 with Venetoclax (VEN) in the 2nd line AML |
| 04/01/2025 15:30 | Announcement of novel patent filing for the DFP-10917 drug product |
| 03/24/2025 15:30 | Announcement for a phase 2/3 study of DFP-17729 to be started |

